Studies have reported that suppression of MGMT expression could enhance the treatment efficacy of temozolomide (TMZ) in human melanoma, glioma, and TMZ‐resistant glioma cells 4, 5, 6, 7, 8. Here, MGMT is linked to central nervous system cancer.